101 results on '"Bouvier, Nancy"'
Search Results
2. 45. Clonal hematopoiesis in childhood cancer survivors
3. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
4. Clonal hematopoiesis in survivors of childhood cancer
5. Clonal evolution during metastatic spread in high-risk neuroblastoma
6. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
7. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
8. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
9. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
10. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
11. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
12. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
13. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
14. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
15. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
16. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
17. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
18. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
19. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
20. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
21. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
22. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
23. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
24. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
25. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
26. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
27. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
28. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
29. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
30. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
31. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
32. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
33. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
34. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
35. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
36. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
37. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
38. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
39. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
40. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
41. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
42. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
43. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
44. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
45. Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma
46. Clonal evolution during metastatic spread in high-risk neuroblastoma
47. Abstract 2590: Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma
48. Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
49. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
50. HGG-35. Radiation Induced High Grade Gliomas: A Single Center Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.